Notre actualité
HCS Pharma team enjoyed attending BioFit 2018 and hosted events in Lille last week! Our business developer Nathalie had many fruitful BtoB meetings along the convention, and our study director Elodie could meet lots of Read more…
We are developing a new BIOMIMESYS® hydroscaffold for neuronal cells. First results are very promising because neurons grow and form neurites. Moreover cells lived longer than in monolayer culture. We are currently finalizing this new Read more…
We will be happy to meet you on Biofit, Lille, France, on December 4th & 5th, 2018 at the business convention or on our Booth D4/2 on Eurasanté/pole NSL Pavillion located at the center of Read more…
Our study directors Elodie and Pierre-Jean will attend “HI Europe” in Frankfurt next week. We cordially invite you to discuss with them, they will be happy to present our imaging services related to nutraceutical testing! We Read more…
This year, the ESTIV (European Society of Toxicology In Vitro) congress took place in Berlin and was again a very interesting symposium. The plenary session was open by a presentation on 3D models made by bioengineering Read more…
HCS Pharma will be present to the annual congress of the Society of Study of Blood-Brain Interfaces (SEISC) at Collège de France on Friday, November 9th 2018. The congress will begin by a plenary lecture Read more…
Last week we attended ELRIG UK Drug Discovery meeting in ExCeL London, and it was a great pleasure for us to present our poster about neurotoxicity testing using HCS there. Many interesting posters were displayed Read more…
Are your interested in meaning full images and high content analysis to asses your compounds properties ? Pierre-Jean, our dermocosmetic expert, will be present at Cosmetic 360 (the international trade fair for innovative ideas and Read more…
The 20th International Congress on In Vitro Toxicology (ESTIV2018) is coming and it will be a great occasion for HCS-Pharma to showcase our current co-development, with the institute du thorax of Nantes and the RHU Read more…
Dans le cadre de notre développement et de l’ouverture d’un second laboratoire à Lille, nous recherchons une apprentie ou un apprenti “business developer” pour le développement des marchés cosmétique, nutraceutique et toxicologique pour le laboratoire de Rennes. La personne aura Read more…
The 2018 Nobel Prize in Physiology or Medicine has been awarded to James Allisson and Tasuku Honjo for their research about immunotherapy to treat cancer. This therapeutic strategy is based on immune checkpoint targeting. Immune Read more…
In HCS Pharma we strongly believe that 3D is the right way to improve drugs dicovery processes. It’s why we develop our 3D hydroscaffold matrix BIOMIMESYS® for 3D cell culture and we invest in 3D Read more…
Nous sommes à la recherche d’un stagiaire BTS pour fin 2018, pour notre site HCS Pharma de Loos. La personne recrutée travaillera sur un projet R&D en oncologie (culture cellulaire et imagerie). Le projet R&D Read more…
Our study director Elodie will attend Drug Discovery 2018 – THE ELRIG‘s flagship conference – which will take place in London next week! We are looking forward to presenting our poster about neurotoxicity testing. Don’t hesitate to visit Read more…
We are very happy to be highlighted by our partner Molecular Devices in this article : “HCS Pharma uses ImageXpress Micro Confocal Systems for phenotypic screening of physiologically relevant 3D cell models”. We have made a Read more…
Nos différents produits BIOMIMESYS® sont disponibles depuis le début de cette année et nous attachons beaucoup d’importance aux retours de nos clients, à leurs remarques et à leurs questions. Pour simplifier la communication avec notre Read more…
It is a great pleasure for us to welcome a new member in our scientific advisory board, Dr Samuel Meignan! He will for sure help us to develop relevant models related to oncology therapeutic area. Read more…
I was really pleased to participate in the kick-off meeting for the launch of NanoSTEM project, a European Marie Skłodowska-Curie Innovative Training Network (ITN) project, this summer. NanoSTEM is a multidisciplinary and innovative project including 11 Read more…
“Regulation needs to catch up with innovation.” Henry Paulson – CEO Goldman Sachs A very nice state of art about animal testing and its alternatives can be found in the new article “Animal Testing and its Read more…
Melanoma is a type of skin cancer that develops from cells called melanocytes, is one of the fastest-growing and deadliest cancer in the world. It usually caused by DNA damage resulting from exposure to ultraviolet Read more…
Last week, HCS Pharma had the pleasure to attend to COSM’ING 2018 for their 20th anniversary which took place in the Palais du Grand Large at Saint Malo from the 4th to 6th July ! Read more…
Last week we had the pleasure to attend the first SLAS Europe (Society for Laboratory Automation and Screening) meeting, which took place in the great Brussels Square meeting centre (Belgium) between the 27th and the Read more…
HCS pharma has organized its second scientific advisory board! We were pleased to gather around the table (physically or via a Webex visioconference for those who could not make the trip) David Devos, Roméo Cecchelli, Read more…